References
- Adolph T.E., Mayr L., Grabherr F., Schwärzler J., Tilg H.: Pancreas-Microbiota Cross Talk in Health and Disease. Annual review of nutrition, 39, 249–266 (2019) DOI: 10.1146/annurev-nutr-082018-124306
- Alonso-Curbelo D. & Lowe S.W.: A gene-environment-induced epigenetic program initiates tumorigenesis. Nature, 590 (7847), 642–648 (2021) DOI: 10.1038/s41586-020-03147-x
- Andréasson K., Olofsson T., Lagishetty V., Alrawi Z., Klaassens E., Holster S., Hesselstrand R., Jacobs J.P., Wallman J.K., Volkmann E.R.: Treatment for Rheumatoid Arthritis Associated With Alterations in the Gastrointestinal Microbiota. ACR open rheumatology, 6 (7), 421–427 (2024) DOI: 10.1002/acr2.11673
- Aykut B. & Miller G. et al.: The fungal mycobiome promotes pancreatic oncogenesis via activation of MBL. Nature, 574 (7777), 264–267 (2019) DOI: 10.1038/s41586-019-1608-2
- Baylin S.B. & Jones P.A.: Epigenetic Determinants of Cancer. Cold Spring Harbor perspectives in biology, 8 (9), a019505 (2016) DOI: 10.1101/cshperspect.a019505
- Chen X., Zeh H.J., Kang R., Kroemer G., Tang D.: Cell death in pancreatic cancer: from pathogenesis to therapy. Nature reviews. Gastroenterology & hepatology, 18 (11), 804–823 (2021) DOI: 10.1038/s41575-021-00486-6
- Chen T. & Liu S. et al.: Alterations of commensal microbiota are associated with pancreatic cancer. The International journal of biological markers, 38 (2), 89–98 (2023) DOI: 10.1177/03936155231166721
- Daley D. & Miller G. et al.: NLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma. The Journal of experimental medicine, 214 (6), 1711–1724 (2017) DOI: 10.1084/jem.20161707
- Daley D.: The role of the microbiome in pancreatic oncogenesis. International immunology, 34 (9), 447–454 (2022) DOI: 10.1093/intimm/dxac036
- Del Castillo E. & Michaud D. S. et al.: The Microbiomes of Pancreatic and Duodenum Tissue Overlap and Are Highly Subject Specific but Differ between Pancreatic Cancer and Noncancer Subjects. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 28 (2), 370–383 (2019) DOI: 10.1158/1055-9965.EPI-18-0542
- Dewhirst F.E., Chen T., Izard J., Paster B.J., Tanner A.C., Yu W.H., Lakshmanan A., Wade W.G.: The human oral microbiome. Journal of Bacteriology, 192 (19), 5002-17 (2010) DOI: 10.1128/JB.00542-10
- Dickson I.: Microbiome promotes pancreatic cancer. Nature reviews. Gastroenterology & hepatology, 15 (6), 328 (2018) DOI: 10.1038/s41575-018-0013-x
- Edogawa S. & Grover M. et al.: Serine proteases as luminal mediators of intestinal barrier dysfunction and symptom severity in IBS. Gut, 69 (1), 62–73 (2020) DOI: 10.1136/gut-jnl-2018-317416
- Fan X. & Ahn J. et al.: Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case-control study. Gut, 67 (1), 120–127 (2018) DOI: 10.1136/gutjnl-2016-312580
- Fitzgerald A.A. & Weiner L.M. et al.: DPP inhibition alters the CXCR3 axis and enhances NK and CD8+ T cell infiltration to improve anti-PD1 efficacy in murine models of pancreatic ductal adenocarcinoma. Journal for immunotherapy of cancer, 9 (11), e002837 (2021) DOI: 10.1136/jitc-2021-002837
- Fulop D.J., Zylberberg H.M., Wu Y.L., Aronson A., Labiner A.J., Wisnivesky J., Cohen D.J., Sigel K.M., Lucas A.L.: Association of Antibiotic Receipt With Survival Among Patients With Metastatic Pancreatic Ductal Adenocarcinoma Receiving Chemotherapy. JAMA network open, 6 (3), e234254 (2023) DOI: 10.1001/jamanetworkopen.2023.4254
- Geller L.T. & Straussman R. et al.: Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine. Science (New York, N.Y.), 357 (6356), 1156–1160 (2017) DOI: 10.1126/science.aah5043
- Gentiluomo M., Canzian F., Nicolini A., Gemignani F., Landi S., Campa D.: Germline genetic variability in pancreatic cancer risk and prognosis. Seminars in cancer biology, 79, 105–131 (2022) DOI: 10.1016/j.semcancer.2020.08.003
- Gnanasekaran J. & Nussbaum G. et al.: Intracellular Porphyromonas gingivalis Promotes the Tumorigenic Behavior of Pancreatic Carcinoma Cells. Cancers, 12 (8), 2331 (2020) DOI: 10.3390/cancers12082331
- Goggins M. & Bruno M. et al.: Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium. Gut, 69 (1), 7–17 (2020) DOI: 10.1136/gutjnl-2019-319352
- Grant T.J., Hua K., Singh A.: Molecular Pathogenesis of Pancreatic Cancer. Progress in molecular biology and translational science, 144, 241–275 (2016) DOI: 10.1016/bs.pmbts.2016.09.008
- Guerra C., Schuhmacher A.J., Cañamero M., Grippo P.J., Verdaguer L., Pérez-Gallego L., Dubus P., Sandgren E.P., Barbacid M.: Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice. Cancer cell, 11 (3), 291–302 (2007) DOI: 10.1016/j.ccr.2007.01.012
- Half E. & Gophna U. et al.: Fecal microbiome signatures of pancreatic cancer patients. Scientific reports, 9 (1), 16801 (2019) DOI: 10.1038/s41598-019-53041-4
- Hirabayashi M. & Tsugane S. et al.: Helicobacter pylori infection, atrophic gastritis, and risk of pancreatic cancer: A population-based cohort study in a large Japanese population: the JPHC Study. Scientific reports, 9 (1), 6099 (2019) DOI: 10.1038/s41598-019-42365-w
- Hsu W.Y., Lin C.H., Lin C.C., Sung F.C., Hsu C.P., Kao C.H.: The relationship between Helicobacter pylori and cancer risk. European journal of internal medicine, 25 (3), 235–240 (2014) DOI: 10.1016/j.ejim.2014.01.009
- Huang, J. & Ye W. et al.: Helicobacter pylori infection, chronic corpus atrophic gastritis and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort: A nested case-control study. International journal of cancer, 140 (8), 1727–1735 (2017) DOI: 10.1002/ijc.30590
- Human Oral Microbiome Database V3.1 https://www.homd.org/
- Iglesia D., Avci B., Kiriukova M., Panic N., Bozhychko M., Sandru V., de-Madaria E., Capurso G.: Pancreatic exocrine insufficiency and pancreatic enzyme replacement therapy in patients with advanced pancreatic cancer: A systematic review and meta-analysis. United European gastroenterology journal, 8 (9), 1115–1125 (2020) DOI: 10.1177/2050640620938987
- Imai H. & Ishioka C. et al.: Antibiotic therapy augments the efficacy of gemcitabine-containing regimens for advanced cancer: a retrospective study. Cancer management and research, 11, 7953–7965 (2019) DOI: 10.2147/CMAR.S215697
- Kaci G. & Delorme C. et al.: Anti-inflammatory properties of Streptococcus salivarius, a commensal bacterium of the oral cavity and digestive tract. Applied and environmental microbiology, 80 (3), 928–934 (2014) DOI: 10.1128/AEM.03133-13
- Kostic A.D. & Garrett W.S. et al.: Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell host & microbe, 14 (2), 207–215 (2013) DOI: 10.1016/j.chom.2013.07.007
- Le D.T. & Laheru D.A. et al.: Evaluation of ipilimumab in combination with allogeneic pancreatic tumor cells transfected with a GM-CSF gene in previously treated pancreatic cancer. Journal of immunotherapy (Hagerstown, Md.: 1997), 36 (7), 382–389 (2013) DOI: 10.1097/CJI.0b013e31829fb7a2
- Lu H. & Li L. et al.: Tongue coating microbiome data distinguish patients with pancreatic head cancer from healthy controls. Journal of oral microbiology, 11 (1), 1563409 (2019) DOI: 10.1080/20002297.2018.1563409
- Maekawa T. & Miyoshi E. et al.: Possible involvement of Enterococcus infection in the pathogenesis of chronic pancreatitis and cancer. Biochemical and biophysical research communications, 506 (4), 962–969 (2018) DOI: 10.1016/j.bbrc.2018.10.169
- Maev I. V., Levchenko A. I., Galeeva J. S., Andreev D. N., Osipenko J. V., Bordin D. S., Ilyina E. N.: Comparative analysis of the intestinal microbiota in patients with exocrine pancreatic insufficiency of various severity. Terapevticheskii Arkhiv, 95 (2), 130-139 (2023) DOI: 10.26442/00403660.2023.02.202056
- Maisonneuve P., Lowenfels A. B.: Risk factors for pancreatic cancer: a summary review of meta-analytical studies. International journal of epidemiology, 44 (1), 186–198 (2015) DOI: 10.1093/ije/dyu240
- Maitra A., Topol E.J.: Early detection of pancreatic cancer and AI risk partitioning. Lancet (London, England), 403 (10435), 1438 (2024) DOI: 10.1016/S0140-6736(24)00690-1
- Meng C., Bai C., Brown T.D., Hood L.E., Tian Q.: Human Gut Microbiota and Gastrointestinal Cancer. Genomics, proteomics & bioinformatics, 16 (1), 33–49 (2018) DOI: 10.1016/j.gpb.2017.06.002
- Michaud D.S. & Riboli E. et al.: Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study. Gut, 62 (12), 1764–1770 (2013) DOI: 10.1136/gutjnl-2012-303006
- Mitsuhashi K. & Shinomura Y. et al.: Association of Fusobacterium species in pancreatic cancer tissues with molecular features and prognosis. Oncotarget, 6 (9), 7209–7220 (2015) DOI: 10.18632/oncotarget.3109
- Montenegro M.L., Corral J.E., Lukens F.J., Ji B., Kröner P.T., Farraye F.A., Bi Y.: Pancreatic Disorders in Patients with Inflammatory Bowel Disease. Digestive diseases and sciences, 67 (2), 423–436 (2022) DOI: 10.1007/s10620-021-06899-2
- Nagata N. & Kawai T. et al.: Metagenomic Identification of Microbial Signatures Predicting Pancreatic Cancer From a Multinational Study. Gastroenterology, 163 (1), 222–238 (2022) DOI: 10.1053/j.gastro.2022.03.054
- Nearing J.T., DeClercq V., Van Limbergen J., Langille M.G.I.: Assessing the Variation within the Oral Microbiome of Healthy Adults. mSphere, 5 (5), e00451-20 (2020) DOI: 10.1128/mSphere.00451-20
- Nejman D. & Straussman R. et al.: The human tumor microbiome is composed of tumor type-specific intracellular bacteria. Science (New York, N.Y.), 368 (6494), 973–980 (2020) DOI: 10.1126/science.aay9189
- Nii T. & Takeda K. et al.: Genomic repertoires linked with pathogenic potency of arthritogenic Prevotella copri isolated from the gut of patients with rheumatoid arthritis. Annals of the rheumatic diseases, 82 (5), 621–629 (2023) DOI: 10.1136/ard-2022-222881
- Nishiyama H., Nagai T., Kudo M., Okazaki Y., Azuma Y., Watanabe T., Goto S., Ogata H., Sakurai T.: Supplementation of pancreatic digestive enzymes alters the composition of intestinal microbiota in mice. Biochemical and biophysical research communications, 495 (1), 273–279 (2018) DOI: 10.1016/j.bbrc.2017.10.130
- O’Reilly E.M. & Philip P.A. et al.: Durvalumab With or Without Tremelimumab for Patients With Metastatic Pancreatic Ductal Adenocarcinoma: A Phase 2 Randomized Clinical Trial. JAMA oncology, 5 (10), 1431–1438 (2019) DOI: 10.1001/jamaoncol.2019.1588
- Parada Venegas D., De la Fuente M.K., Landskron G., González M.J., Quera R., Dijkstra G., Harmsen H.J.M., Faber K.N., Hermoso M.A. Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases. Frontiers in immunology, 10, 277 (2019) DOI: 10.3389/fimmu.2019.00277
- PDQ Adult Treatment Editorial Board. Pancreatic Cancer Treatment (PDQ®): Patient Version. In PDQ Cancer Information Summaries. National Cancer Institute (US). (2024)
- Pietzner M., Budde K., Rühlemann M., Völzke H., Homuth G., Weiss F.U., Lerch M.M., Frost F.: Exocrine Pancreatic Function Modulates Plasma Metabolites Through Changes in Gut Microbiota Composition. The Journal of clinical endocrinology and metabolism, 106 (5), e2290–e2298 (2021) DOI: 10.1210/clinem/dgaa961
- Plottel C.S., Blaser M.J.: Microbiome and malignancy. Cell host & microbe, 10 (4), 324–335 (2011) DOI: 10.1016/j.chom.2011.10.003
- Pourali G. & Avan A. et al.: Microbiome as a biomarker and therapeutic target in pancreatic cancer. BMC microbiology, 24 (1), 16 (2024) DOI: 10.1186/s12866-023-03166-4
- Pushalkar S. & Miller G. et al.: The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression. Cancer discovery, 8 (4), 403–416 (2018) DOI: 10.1158/2159-8290.CD-17-1134
- Ramanathan R.K. & Von Hoff D.D. et al.: Positron emission tomography response evaluation from a randomized phase III trial of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone for patients with metastatic adenocarcinoma of the pancreas. Annals of oncology: official journal of the European Society for Medical Oncology, 27 (4), 648–653 (2016) DOI: 10.1093/annonc/mdw020
- Ren Z. & Zheng S. et al.: Gut microbial profile analysis by MiSeq sequencing of pancreatic carcinoma patients in China. Oncotarget, 8 (56), 95176–95191 (2017) DOI: 10.18632/oncotarget.18820
- Riquelme E. & McAllister F. et al. Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes. Cell, 178 (4), 795–806.e12 (2019) DOI: 10.1016/j.cell.2019.07.008
- Risch H.A., Lu L., Kidd M.S., Wang J., Zhang W., Ni Q., Gao Y.T., Yu H.: Helicobacter pylori seropositivities and risk of pancreatic carcinoma. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 23 (1), 172–178 (2014) DOI: 10.1016/j.cell.2019.07.008
- Risch H.A.: Pancreatic cancer: Helicobacter pylori colonization, N-nitrosamine exposures, and ABO blood group. Molecular carcinogenesis, 51 (1), 109–118 (2012) DOI: 10.1002/mc.20826
- Sabater L. & de-Madaria E. et al.: Evidence-based Guidelines for the Management of Exocrine Pancreatic Insufficiency After Pancreatic Surgery. Annals of surgery, 264 (6), 949–958 (2016) DOI: 10.1097/SLA.0000000000001732
- Santucci C., Mignozzi S., Malvezzi M., Boffetta P., Collatuzzo G., Levi F., La Vecchia C., Negri E.: European cancer mortality predictions for the year 2024 with focus on colorectal cancer. Annals of oncology: official journal of the European Society for Medical Oncology, 35 (3), 308–316 (2024) DOI: 10.1016/j.annonc.2023.12.003
- Seifert L. & Miller G. et al.: The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression. Nature, 532 (7598), 245–249 (2016) DOI: 10.1038/nature17403
- Sevcikova A., Izoldova N., Stevurkova V., Kasperova B., Chovanec M., Ciernikova S., Mego M.: The Impact of the Microbiome on Resistance to Cancer Treatment with Chemotherapeutic Agents and Immunotherapy. International journal of molecular sciences, 23 (1), 488 (2022) DOI: 10.3390/ijms23010488
- Sexton R.E. & Azmi A.S. et al.: Connecting the Human Microbiome and Pancreatic Cancer. Cancer metastasis reviews, 41 (2), 317–331 (2022) DOI: 10.1007/s10555-022-10022-w
- Shi H., Tsang Y., Yang Y., Chin H.L.: Identification of ONECUT3 as a stemness-related transcription factor regulating NK cell-mediated immune evasion in pancreatic cancer. Scientific reports, 13 (1), 18133 (2023) https://doi.org/10.3390/ijms26020515
- Shin J.H., Seeley R.J.: Reg3 Proteins as Gut Hormones? Endocrinology, 160 (6), 1506–1514 (2019) DOI: 10.1210/en.2019-00073
- Siegel R.L., Giaquinto A.N., Jemal A.: Cancer statistics, 2024. CA: a cancer journal for clinicians, 74 (1), 12–49 (2024) DOI: 10.3322/caac.21820
- Siegel R.L., Miller K.D., Wagle N.S., Jemal A.: Cancer statistics, 2023. CA: a cancer journal for clinicians, 73 (1), 17–48 (2023) DOI: 10.3322/caac.21763
- Speth C., Bellotti R., Schäfer G., Rambach G., Texler B., Thurner G.C., Öfner D., Lass-Flörl C., Maglione M.: Complement and Fungal Dysbiosis as Prognostic Markers and Potential Targets in PDAC Treatment. Current oncology (Toronto, Ont.), 29 (12), 9833–9854 (2022) DOI: 10.3390/curroncol29120773
- Stanciu S., Ionita-Radu F., Stefani C., Miricescu D., Stanescu-Spinu I.I., Greabu M., Ripszky Totan A., Jinga M.: Targeting PI3K/AKT/mTOR Signaling Pathway in Pancreatic Cancer: From Molecular to Clinical Aspects. International journal of molecular sciences, 23 (17), 10132 (2022) DOI: 10.3390/ijms231710132
- Frost F. & Lerch M.M. et al.: Impaired Exocrine Pancreatic Function Associates With Changes in Intestinal Microbiota Composition and Diversity. Gastroenterology, 156(4), 1010– 1015 (2019) DOI: 10.1053/j.gastro.2018.10.047
- Farrell J.J., Zhang L., Zhou H., Chia D., Elashoff D., Akin D., Paster B.J., Joshipura K., Wong D.T.: Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer. Gut, 61 (4), 582–588 (2012) DOI: 10.1136/gutjnl-2011-300784
- Stein-Thoeringer C.K. & Ilmer M. et al.: Microbiome Dysbiosis With Enterococcus Presence in the Upper Gastrointestinal Tract Is a Risk Factor for Mortality in Patients Undergoing Surgery for Pancreatic Cancer. Annals of surgery, 281 (4), 615–623. (2025) DOI: 10.1097/SLA.0000000000006210
- Thomas R.M., Jobin C.: Microbiota in pancreatic health and disease: the next frontier in microbiome research. Nature reviews. Gastroenterology & hepatology, 17 (1), 53–64 (2020) DOI: 10.1038/s41575-019-0242-7
- Ubachs J. & Rensen S.S. et al.: Gut microbiota and short-chain fatty acid alterations in cachectic cancer patients. Journal of cachexia, sarcopenia and muscle, 12 (6), 2007–2021 (2021) DOI: 10.1002/jcsm.12804
- Ungureanu B.S. & Surlin P. et al.: Could there be an interplay between periodontal changes and pancreatic malignancies? World journal of clinical cases, 11 (3), 545–555 (2023) DOI: 10.12998/wjcc.v11.i3.545
- Vujasinovic M., Valente R., Del Chiaro M., Permert J., Löhr J.M.: Pancreatic Exocrine Insufficiency in Pancreatic Cancer. Nutrients, 9 (3), 183 (2017) DOI: 10.3390/nu9030183
- Wang S.S., Xu J., Ji K.Y., Hwang C.I.: Epigenetic Alterations in Pancreatic Cancer Metastasis. Biomolecules, 11 (8), 1082 (2021) DOI: 10.3390/biom11081082
- Wang Y., Zhang F.C., Wang Y.J.: Helicobacter pylori and pancreatic cancer risk: a meta-analysis based on 2,049 cases and 2,861 controls. Asian Pacific journal of cancer prevention: APJCP, 15 (11), 4449–4454 (2014) DOI: 10.7314/apjcp.2014.15.11.4449
- Wei A.L. & Fu M.R. et al.: Oral microbiome and pancreatic cancer. World journal of gastroenterology, 26 (48), 7679–7692 (2020) DOI: 10.3748/wjg.v26.i48.7679
- Wu R.T., Wang L.F., Yao Y.F., Sang T., Wu Q.L., Fu W.W., Wan M., Li W. J.: Activity fingerprinting of polysaccharides on oral, gut, pancreas and lung microbiota in diabetic rats. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 155, 113681 (2022) DOI: 10.1016/j.biopha.2022.113681
- Xu W., Zhou X., Yin M., Gao J., Weng Z., Xu C.: The relationship between Helicobacter pylori and pancreatic cancer: a meta-analysis. Translational cancer research, 11 (8), 2810–2822 (2022) DOI: 10.21037/tcr-21-2803
- Yang Q., Zhang J., Zhu Y.: Potential Roles of the Gut Microbiota in Pancreatic Carcinogenesis and Therapeutics. Frontiers in cellular and infection microbiology, 12, 872019 (2022) DOI: 10.3389/fcimb.2022.872019
- Yu Q., Newsome R.C., Beveridge M., Hernandez M.C., Gharaibeh R.Z., Jobin C., Thomas R.M.: Intestinal microbiota modulates pancreatic carcinogenesis through intratumoral natural killer cells. Gut microbes, 14 (1), 2112881 (2022) DOI: 10.1080/19490976.2022.2112881
- Yu T. & Fang J.Y. et al.: Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy. Cell, 170 (3), 548–563.e16. (2017) DOI: 10.1016/j.cell.2017.07.008
- Zhang S., Yang Y., Weng W., Guo B., Cai G., Ma Y., Cai S.: Fusobacterium nucleatum promotes chemoresistance to 5-fluorouracil by upregulation of BIRC3 expression in colorectal cancer. Journal of experimental & clinical cancer research: CR, 38 (1), 14. (2019) DOI: 10.1186/s13046-018-0985-y
- Zhou C.H. & Zou D.W. et al.: Altered diversity and composition of gut microbiota in Chinese patients with chronic pancreatitis. Pancreatology (IAP), 20 (1), 16–24 (2020) DOI: 10.1016/j.pan.2019.11.013